Portola Pharmaceuticals

Healthcare 📍 South San Francisco, United States 👥 1-10 employees 💰 $249.1M raised 📅 Founded 2003

Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

1-10

Total Raised · Private Equity

$249.1M

Founded

2003

Cloud

AWS

CDN

AWS CloudFront

Email

Proofpoint

☁️ Cloud Infrastructure

AWS Detected Cloud Provider

Detected via HTTP headers

Workspace	Proofpoint
CDN	AWS CloudFront

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K – $45K / year on AWS

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Portola Pharmaceuticals's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction